Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification [PDF]
, 2022 To investigate associations and predictive factors between macular neovascularization (MNV) lesion variants and drusen types in patients with treatment-naïve neovascular age-related macular degeneration (AMD).
Bajka, Anahita +10 more
core +1 more source
Inner Retinal Layer Thickness Alterations in Early Age Related Macular Degeneration in Eyes with Subretinal Drusenoid Deposits or Conventional Drusen [PDF]
, 2021 The purpose of this study was to evaluate central and parafoveal inner retinal layer thickness in patients with subretinal drusenoid deposits (SDD) or conventional drusen (CD). Participants underwent comprehensive ophthalmoscopic examination. Evidence of
Abdolrahimzadeh, Solmaz +3 more
core +2 more sources
Scientific Reports, 2021 This study aimed to quantify the Haller vessel and choriocapillaris (CC) parameters in drusen subtypes in nonexudative age-related macular degeneration (AMD) and pachydrusen.
Hyungwoo Lee +6 more
doaj +1 more source
Scientific Reports, 2022 Age-related macular degeneration (AMD) is the most widespread cause of blindness and the identification of baseline AMD features or biomarkers is critical for early intervention.
Shuxian Wang +6 more
doaj +1 more source
Drusenoid pigment epithelial detachments and age-related macular degeneration [PDF]
, 2020 Patients with age-related macular degeneration (AMD) and serous or drusenoid pigment epithelial detachments (PEDs) have a high risk of progression to geographic atrophy, choroidal neovascularization, and a loss of visual function. The abundance of lipids
Tvenning, Arnt-Ole
core +1 more source
Retinal progression biomarkers of early and intermediate age-related macular degeneration [PDF]
, 2021 Funding Information: Funding: This work was supported by Fundação para a Ciência e Tecnologia project PTDC/MED-PAT/30385/2017 and iNOVA4Health-UIDB/04462/2020, a program financially supported by Fun-dação para a Ciência e Tecnologia/Ministério da ...
Carneiro, Ângela +3 more
core +2 more sources
Acta Ophthalmologica, Volume 101, Issue 8, Page 839-856, December 2023., 2023 Abstract Globally age‐related macular degeneration (AMD) is a leading cause of blindness with a significant impact on quality of life. Geographic atrophy (GA) is the atrophic late form of AMD and its prevalence increases markedly with age with around 1 in 5 persons aged 85 and above having GA in at least one eye.
Stela Vujosevic +2 more
wiley +1 more source
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group [PDF]
, 2020 © 2019 American Academy of Ophthalmology Purpose: To establish a process to evaluate and standardize a state-of-the-art nomenclature for reporting neovascular age-related macular degeneration (AMD) data. Design: Consensus meeting.
+25 additional authors +10 more
core +2 more sources
Quantification of key retinal features in early and late age-related macular degeneration using deep learning [PDF]
, 2021 PURPOSE: To develop and validate a deep learning model for segmentation of 13 features associated with neovascular and atrophic age-related macular degeneration (AMD).
Alsaedi, A +18 more
core +1 more source
Acta Ophthalmologica, Volume 101, Issue 8, Page 881-890, December 2023., 2023 Abstract Geographic atrophy (GA) secondary to age‐related macular degeneration is among the most common causes of irreversible vision loss in industrialized countries. Recently, two therapies have been approved by the US FDA. However, given the nature of their treatment effect, which primarily involves a relative decrease in disease progression ...
Maximilian Pfau +5 more
wiley +1 more source